COVID19 News
-
Vaccitech, Oxford University tie up with AstraZeneca for COVID-19 vaccine
COVID19 | News | 0 Comment | 01 May, 2020
Vaccitech Ltd and the University of Oxford have announce an agreement with the UK-based global biopharmaceutical company...Read more
-
CEPI invests $3.5M in Clover Australia for COVID-19 vaccine
COVID19 | News | 0 Comment | 01 May, 2020
Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...Read more
-
Biolidics launches rapid test kit for COVID-19
COVID19 | News | 2 Comment | 01 May, 2020
A rapid test kit for COVID-19 launched by former National University of Singapore (NUS) startup company, medtech firm Bi...Read more
-
360biolabs supports first Australian COVID-19 vaccine trial
COVID19 | News | By Ankit Kankar | 0 Comment | 30 Apr, 2020
In one of the first COVID-19 clinical vaccine trials, US-based clinical-stage biotechnology company Novavax has selected...Read more
-
Japan observes cross protection from COVID-19 by JEV
COVID19 | News | 0 Comment | 30 Apr, 2020
A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection ...Read more
-
HKBU unveils COVID-19 transmission patterns
COVID19 | News | 0 Comment | 29 Apr, 2020
New research led by Hong Kong Baptist University (HKBU) computer scientists has used a data-driven modelling a...Read more
-
Seasun Biomaterials set to launch COVID-19 rapid kit
COVID19 | News | 0 Comment | 29 Apr, 2020
South Korea based SEASUN BIOMATERIALS has announced that they are about to release their second COVID-19 assay "AQ-TOP C...Read more
-
Vela Diagnostics Receives BARDA Funding to Develop COVID-19 Tests
COVID19 | News | 0 Comment | 29 Apr, 2020
Vela Diagnostics has been awarded a $225,000 contract by the Biomedical Advanced Research and Development Authority (BAR...Read more
-
Vela Diagnostics receives CE mark for COVID-19 test
COVID19 | News | 0 Comment | 30 Apr, 2020
Singapore headquartered Vela Diagnostics announced that the manual version of the ViroKey™ SARS-CoV-2 RT-PCR Test ...Read more
-
Singapore develops comprehensive medical strategy for COVID-19
COVID19 | News | 0 Comment | 29 Apr, 2020
The Multi-Ministry Taskforce in Singapore has a comprehensive medical strategy to ensure that individuals infected with ...Read more
-
NanoPass joins pharma partners for COVID-19 vaccine development
COVID19 | News | 0 Comment | 27 Apr, 2020
Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...Read more
-
COVID19 | News | By Ankit Kankar | Covid19 Special Analytical Reporting | 0 Comment | 27 Apr, 2020
Countries are reporting testing data in different ways: some report the number of tests, others report the number of peo...Read more
-
Australia boosts COVID-19 response with additional $3M
COVID19 | News | 0 Comment | 28 Apr, 2020
The Australian Government will provide a further $3 million to support frontline health workers with training and inform...Read more
-
MiRXES to distribute A*STAR's SARS-CoV-2 RT-PCR test
COVID19 | News | 0 Comment | 28 Apr, 2020
MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Author...Read more
-
Terumo donates $2.4 M for COVID-19 fight
COVID19 | News | 0 Comment | 28 Apr, 2020
As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...Read more
-
Singapore designs AI platform to combat infectious diseases
COVID19 | News | 0 Comment | 27 Apr, 2020
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective trea...Read more
-
Scientists identify key nasal cells believed to attract Coronavirus
COVID19 | News | 0 Comment | 24 Apr, 2020
Two specific nose cell types have been identified as likely initial infection points for COVID-19 coronavirus. Scientist...Read more
-
CanSino Bio enrols for Ph 2 trial of COVID-19 vaccine
COVID19 | News | 0 Comment | 27 Apr, 2020
China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...Read more
